Conference attendance can be a big part of your travel budget, and with these being limited at times, it’s important to make the most of the opportunity. Here we list a few pointers to help you focus. List five things you hope to learn. Select sessions to attend or trade booths to visit, preferably before…
DetailsBy Amy Rothman Schonfeld Print journals remain one of the most credible sources for disseminating health economic research findings, and there is consensus about which are the core publications for communications within the field. At least some health economists are stepping out of their “health economics shell” and looking beyond these traditional research outlets to…
DetailsMay 2006 marks the arrival of Greenflint – Rx Communications’ sister company – to be officially launched during ISPOR’s 11th Annual International meeting at the Marriott in Philadelphia, USA , from 20–24 May 2006. At Greenflint we understand the increasing significance of health economics and outcomes research in drug development and marketing, and in healthcare…
DetailsEach issue we will include a few common errors that crop up time and time again. If you have a personal favourite you think we should add to this section, please email me and I will try to include it in a future issue of HOC. Dangerous Dyads Anesthesia, Anesthetic Terms are not interchangeable. Anesthetics…
DetailsBy Clare Gurton Giving talks and presentations is never easy but sometimes things go very much more smoothly after a mistake. This may sound strange but by letting your audience see that you are human, you can effectively burst the bubble and get the audience on your side. I remember an occasion when satellite links…
DetailsBy Robert Hand Health economics data play an increasingly important role in getting pharmaceuticals accepted for the drug formularies established by health insurance plans and regulatory authorities. A drug manufacturer needs to know how to use health economics data to gain acceptance for its drugs. One way is to gather case studies to show which…
DetailsBy HOC Editor, Mary Gabb ([email protected]) When speaking to non-economists, do you end up feeling that you’ve made a difficult science completely unintelligible? It doesn’t have to be that way. Kevin Frick, PhD, Associate Professor of Health Policy and Management at the Health Services Research and Development Center, Johns Hopkins Bloomberg School of Public Health,…
DetailsA pharmaceutical executive working in the field of health outcomes tells former HOC editor David Woods how he deals with this issue. The best way to communicate value in a product using economics is to know your customers: find out their issues and their language. Look closely at what the product has to offer. Ask:…
DetailsBy Amy Rothman Schonfeld This spring will mark the inaugural biennial conference of the newly formed American Society of Health Economists (ASHE). The conference, titled Economics of Population Health, is scheduled for June 4–7, 2006 and will be hosted by the University of Wisconsin in Madison. More than 350 presentations and 60 posters have been…
DetailsBy Robert Hand In the United States, there has been growing acceptance of the Academy of Managed Care Pharmacy (AMCP) Drug Dossier format for submitting consistent, evidence-based information about drugs. And Australia, Great Britain, Germany, and other countries have national systems to provide clinicians with comparable information about new drugs. But drug makers fear that…
Details